Securities Antitrust Consumer Fraud FINRA Arbitration Structured Finance Whistleblower/Qui Tam Corporate Governance Mergers & Acquisitions ERISA Healthcare Fraud
PartnersOf Counsel Associates Staff Attorneys All
M & A Investigations New Federal Securities Cases Current CasesSettlements & Class Notices Accolades
Our Institutional Monitoring Service Our ProcessReporting Custom Monitoring
Articles Press Releases Television
Contact Us Join a Class Action Report a Fraud

New Federal Securities Cases

Opko Health, Inc.

A class action lawsuit has been filed in the United States District Court for the District of New Jersey against OPKO Health, Inc. (NASDAQ:OPK) ("OPKO" or the "Company"), on behalf of investors who acquired OPKO securities during the period from September 26, 2013 through September 7, 2018 (the "Class Period"). The lawsuit seeks to recover damages for OPKO investors under the federal securities laws.

OPKO Health is a medical test and medication company focused on diagnostics and pharmaceuticals. According to the lawsuit, OPKO and its Chairman and Chief Executive Officer, Phillip Frost, were engaged in a pump-and-dump scheme with several other individuals and companies in connection with their investments in several penny stocks.

On September 7, 2018, the SEC announced charges of a massive pump-and-dump scheme relating to several companies, including OPKO. When this news was revealed, OPKO's stock price fell from $5.59 to $4.58 per share, before trading was halted. Trading reopened one week later at $4.00 per share.

If you acquired OPKO securities during the Class Period, you may, no later than November 13, 2018, request that the court appoint you lead plaintiff of the Class. Although your ability to share in any recovery is not affected by the decision whether or not to seek appointment as a lead plaintiff, lead plaintiffs make important decisions that could affect the overall recovery for class members, including decisions concerning settlement.

If you are a current or former OPKO shareholder and wish to obtain additional information, please fill out the contact form at the link below.


Investigation Contact Form

Opko Health, Inc. Investor Contact Form


Kirby McInerney LLP | 825 Third Avenue | NYC 10022 | Tel. 212.371.6600 | Fax 212.751.2540

Attorney Advertising - Prior Results do not Guarantee a Similar Outcome




Law Firm Website Design by Business Edge